Tenor Capital Management »

Biomarin Pharmaceutical shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $98M 102M 0.96
2025-06-30 $73M 78M 0.94

More positions owned by Tenor Capital Management

Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Ringcentral Note 3/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Akamai Technologies Note 0.375% 9/0 (Principal)
Unity Software Note 11/1 (Principal)
Cloudflare Note 8/1 (Principal)
Bentley Sys Note 0.125% 1/1 (Principal)
Jamf Hldg Corp Note 0.125% 9/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Haemonetics Corp Mass Note 3/0 (Principal)
Novocure Note 11/0 (Principal)
Tripadvisor Note 0.250% 4/0 (Principal)
Jbt Marel Corporation Note 0.250% 5/1 (Principal)

View all positions for Tenor Capital Management

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical